| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1995;110:1745-1755
© 1995 Mosby, Inc.
SURGERY FOR ACQUIRED HEART DISEASE |
Osaka, Japan, for the 174 centers of the Japanese Association of Thoracic Surgery
From the Division of Cardiovascular Surgery, Division of Neurology, National Cardiovascular Center of Japan, Osaka, Japan. Supported in part by a grant for research on cardiovascular diseases from the Ministry of Health and Welfare, Japan.
Received for publication Dec. 23, 1994. Accepted for publication April 19, 1995. Address for reprints: Kiyoyuki Eishi, MD, Division of Cardiovascular Surgery, National Cardiovascular Center of Japan, 5-7-1 Fujishiro-dai, Suita, Osaka 565, Japan.
Abstract
To establish guidelines for the surgical treatment of patients with infective endocarditis who have cerebrovascular complications, we conducted a detailed retrospective study of 181 of 244 patients with cerebral complications among 2523 surgical cases of infective endocarditis of the Japanese Association of Thoracic Surgery. The results showed that 9.7% of all patients with infective endocarditis had associated cerebral complications: 108 (44.3%) had active native valve endocarditis, 96 (39.3%) had healed native valve endocarditis, and 40 (16.4%) had prosthetic valve endocarditis. The hospital mortality of the patients with cerebral complications was 11.0% in the group as a whole: 13.9% in active native valve endocarditis, 3.1% in healed native valve endocarditis, and 37.5% in prosthetic valve endocarditis. Diseased valves included the following: aortic valve in 55.5%, mitral valve in 49.8%, tricuspid valve in 1.3%, and pulmonary valve in 1.3%. In 181 patients with cerebral complications, organisms were detected as follows: gram-positive cocci in 133 (73.5% [Streptococcus in 85, Staphylococcus in 32]), gram-negative in 18 (9.9%), fungus in 11 (6.1%), and unknown in 19 (10.5%). Types of cerebral complications included cerebral infarction in 64.6%, cerebral bleeding in 31.5%, cerebral abscess in 2.8%, and meningitis in 1.1%. Hospital mortality rate and an exacerbation rate of cerebral complications, including related death, according to the interval from onset of cerebral infarction to cardiac surgery, were as follows: 66.3% and 45.5% within 24 hours, 31.3% and 43.8% between 2 and 7 days, 16.7% and 16.7% between 8 and 14 days, 10.0% and 10.0% between 15 and 21 days, 26.3% and 10.5% between 22 and 28 days, and 7.0% and 2.3% over 4 weeks later, respectively. A significant correlation existed between the interval and the exacerbation of cerebral complications (tied p = 0.008). Preoperative risk factors affecting exacerbation of cerebral complications were as follows: (1) severity of cerebral complication (p = 0.006), (2) intervals (p = 0.012), and (3) uncontrolled congestive heart failure as indications for cardiac surgery (p = 0.014). One patient underwent a cardiac operation within 24 hours of the onset of cerebral hemorrhage and died of cerebral damage. No exacerbations occurred in 10 patients who underwent their operation between 2 and 28 days. Nevertheless, exacerbations occurred in 19.0% of patients whose operation was done more than 4 weeks later. These data suggest that cardiac operations can be done safely 4 weeks after cerebral infarction, and if the delay is more than 2 weeks, the exacerbation rate will be around 10%. The risk of progression of cerebral damage is still significant 15 days and even 4 weeks after cerebral hemorrhage. (J THORAC CARDIOVASC SURG 1995;110:1745-55)
This article has been cited by other articles:
|
|
 |
|
  Endorsed by the European Society of Clinical Micro, Authors/Task Force Members, G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, I. Vilacosta, P. Moreillon, M. de Jesus Antunes, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) Eur. Heart J., October 1, 2009; 30(19): 2369 - 2413. [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Cooper, E. C. Thompson, R. Laureno, A. Fuisz, A. S. Mark, M. Lin, and S. A. Goldstein Subclinical Brain Embolization in Left-Sided Infective Endocarditis: Results From the Evaluation by MRI of the Brains of Patients With Left-Sided Intracardiac Solid Masses (EMBOLISM) Pilot Study Circulation, August 18, 2009; 120(7): 585 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, October 7, 2008; 118(15): e523 - e661. [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142. [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Stamou, G. Petterson, and A. M. Gillinov Surgical Treatment of Mitral Valve Endocarditis Card. Surg. Adult, January 1, 2008; 3(2008): 1069 - 1078. [Full Text]
|
|
|
|
 |
|
 T. Ota, K. Okada, H. Kano, and Y. Okita Cardiopulmonary bypass using nafamostat mesilate for patients with infective endocarditis and recent intracranial hemorrhage Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 270 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Thuny, J.-F. Avierinos, C. Tribouilloy, R. Giorgi, J.-P. Casalta, L. Milandre, A. Brahim, G. Nadji, A. Riberi, F. Collart, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study Eur. Heart J., May 1, 2007; 28(9): 1155 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148. [Full Text] [PDF]
|
|
|
|
|
|
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al. ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Habib Management of infective endocarditis Heart, January 1, 2006; 92(1): 124 - 130. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Taylor and H. Holtby Methylene blue revisited: Management of hypotension in a pediatric patient with bacterial endocarditis J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 566 - 566. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lydakis, S. Apostolakis, N. Lydataki, E. Tzortzakakis, and G. Komis Stroke-Complicated Endocarditis with Positive Lupus Anticoagulant: A Case Report Angiology, July 1, 2005; 56(4): 503 - 506. [Abstract] [PDF]
|
|
|
|
|
|
F. Filsoufi and D. H. Adams Surgical Treatment of Mitral Valve Endocarditis Card. Surg. Adult, January 1, 2003; 2(2003): 987 - 997. [Full Text]
|
|
|
|
 |
|
 K.-L. Chan Early clinical course and long-term outcome of patients with infective endocarditis complicated by perivalvular abscess Can. Med. Assoc. J., July 1, 2002; 167(1): 19 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Asai, A. Usui, S. Miyachi, and Y. Ueda Endovascular treatment for intracranial mycotic aneurysms prior to cardiac surgery Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 948 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Marnette, H. Hassan, J. Sarot, and K. Jacobs Papillary fibroelastoma of a mitral valve chorda Eur. J. Cardiothorac. Surg., December 1, 2001; 20(6): 1249 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mylonakis and S. B. Calderwood Infective Endocarditis in Adults N. Engl. J. Med., November 1, 2001; 345(18): 1318 - 1330. [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Rosen, V. G. Fowler Jr., G. R. Corey, S. M. Downs, A. K. Biddle, J. Li, and J. G. Jollis Cost-Effectiveness of Transesophageal Echocardiography To Determine the Duration of Therapy for Intravascular Catheter-Associated Staphylococcus aureus Bacteremia Ann Intern Med, May 18, 1999; 130(10): 810 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Choussat, D. Thomas, R. Isnard, P.-L. Michel, B. Iung, G. Hanania, P. Mathieu, M. David, T. du Roy de Chaumaray, G. De Gevigney, et al. Perivalvular abscesses associated with endocarditis: Clinical features and prognostic factors of overall survival in a series of 233 cases Eur. Heart J., February 1, 1999; 20(3): 232 - 241. [Abstract] [PDF]
|
|
|
|
 |
|
 P. E. Parrino, I. L. Kron, S. D. Ross, K. S. Shockey, A. M. Kron, M. A. Towler, and C. G. Tribble Does a focal neurologic deficit contraindicate operation in a patient with endocarditis? Ann. Thorac. Surg., January 1, 1999; 67(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M Oppenheimer and J. Lima Neurology and the heart J. Neurol. Neurosurg. Psychiatry, March 1, 1998; 64(3): 289 - 297. [Full Text] [PDF]
|
|
|
|
|
|
J.-J. Monsuez, D. Vittecoq, C. Acar, J. Evans, S. Witchitz, and N. Kouchoukos RECURRENT INFECTIVE ENDOCARDITIS ONE YEAR AFTER MITRAL REPAIR IN A WOMAN ADDICTED TO DRUGS J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 864 - 866. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
